特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959879

OTC医薬品・栄養補助食品の世界市場 - 2027年までの予測:COVID-19の影響、製品・タイプ・形状・流通チャネル・地域別の分析

OTC Drug and Dietary Supplement Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ; Type ; Form ; Distribution Channel, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 200 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
OTC医薬品・栄養補助食品の世界市場 - 2027年までの予測:COVID-19の影響、製品・タイプ・形状・流通チャネル・地域別の分析
出版日: 2020年08月24日
発行: The Insight Partners
ページ情報: 英文 200 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

OTC医薬品・栄養補助食品の市場規模は、2019年に2932億5540万米ドルとなり、2027年までに4921億249万米ドルへ達すると予測され、2020年から2027年にかけて6.8%のCAGRで成長すると見込まれています。

当レポートでは、世界のOTC医薬品・栄養補助食品市場について調査分析し、各セグメント・地域別の市場分析と予測、市場発展への影響要因、COVID-19パンデミックが市場に与える影響、競合情勢、主要企業のプロファイルなどについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 OTC医薬品・栄養補助食品:要点

第3章 調査手法

第4章 OTC医薬品・栄養補助食品:市場情勢

  • 概要
  • PEST分析
  • 専門家の見解

第5章 OTC医薬品・栄養補助食品市場:主な市場力学

  • 市場成長促進要因
  • 市場成長抑制要因
  • 市場機会
  • 将来の動向
  • 影響分析

第6章 OTC医薬品・栄養補助食品市場:世界市場の分析

  • 収益・予測
  • 地域別の予測・分析
  • 主要企業の市場ポジショニング

第7章 OTC医薬品・栄養補助食品市場の分析:製品別

  • 概要
  • 収益シェア:製品別
  • 感冒薬
  • ビタミン・栄養補助食品
  • 鎮痛剤
  • 胃腸薬
  • 睡眠補助薬
  • オーラルケア製品
  • 眼科薬
  • 制酸剤
  • フェミニンケア
  • その他

第8章 OTC医薬品・栄養補助食品市場の分析:タイプ別

  • 概要
  • 収益シェア:タイプ別
  • ブランド医薬品
  • ジェネリック医薬品

第9章 OTC医薬品・栄養補助食品市場の分析:形状別

  • 概要
  • シェア:形状別
  • タブレット
  • カプセル
  • 粉末
  • 軟膏
  • 液体
  • その他

第10章 OTC医薬品・栄養補助食品市場の分析:流通チャネル別

  • 概要
  • シェア:流通チャネル別
  • 病院および小売薬局
  • 小売店
  • オンラインチャンネル
  • その他

第11章 OTC医薬品・栄養補助食品市場:地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第12章 COVID-19パンデミックによる世界のOTC医薬品・栄養補助食品市場への影響

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第13章 業界情勢

  • 概要
  • 市場参入企業が行った成長戦略
  • 有機的開発
  • 無機的開発

第14章 企業プロファイル

  • GlaxoSmithKline plc.
  • Sanofi
  • Johnson and Johnson Services, Inc.
  • Abbott
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Procter & Gamble
  • Novartis AG
  • Reckitt Benckiser Group Plc

第15章 付録

  • 用語集
図表

List Of Tables

  • Table 1. North America: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America: OTC Drug and Dietary Supplement Market, By Form - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America: OTC Drug and Dietary Supplement Market, By Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 8. US: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Canada: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Canada: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Mexico: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Mexico: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Mexico: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Mexico: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Europe: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Europe: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Europe: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Germany: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Germany: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Germany: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 24. Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 25. France: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 26. France: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 27. France: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 28. France: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 29. UK: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 30. UK: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 31. UK: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 32. UK: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Italy: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Italy: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Italy: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Spain: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Spain: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Spain: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 40. Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 41. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 44. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 45. China: OTC Drug and Dietary Supplement Market,, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 46. China: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 47. China: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 48. China: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Japan: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Japan: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Japan: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 53. India: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 54. India: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 55. India: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 56. India: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 57. South Korea OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 58. South Korea OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 59. South Korea: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 60. South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 61. Australia: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 62. Australia OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 63. Australia: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Middle East & Africa OTC Drug and Dietary Supplement Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 66. Middle East & Africa OTC Drug and Dietary Supplement Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 67. Middle East & Africa OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Middle East & Africa OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Saudi Arabia: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Saudi Arabia: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Saudi Arabia: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
  • Table 72. Saudi Arabia: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)
  • Table 73. UAE: OTC Drug and Dietary Supplement Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 74. UAE: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 75. UAE: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
  • Table 76. UAE: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 77. South Africa: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 78. South Africa: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 79. South Africa: OTC Drug and Dietary Supplement Market, by Form- Revenue and Forecast to 2027(USD Million)
  • Table 80. South Africa: OTC Drug and Dietary Supplement Market, by Distribution Channel- Revenue and Forecast to 2027(USD Million)
  • Table 81. South and Central America: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 82. South and Central America: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 83. South and Central America: OTC Drug and Dietary Supplement Market, by Form- Revenue and Forecast to 2027(USD Million)
  • Table 84. South and Central America: OTC Drug and Dietary Supplement Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 85. Brazil: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 86. Brazil: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 87. Brazil: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
  • Table 88. Brazil: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)
  • Table 89. Argentina: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 90. Argentina: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 91. Argentina: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
  • Table 92. Argentina: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)
  • Table 93. Organic Developments Done By Companies
  • Table 94. Inorganic Developments Done By Companies
  • Table 95. Glossary of Terms, OTC Drug and Dietary Supplement

List Of Figures

  • Figure 1. OTC Drug and Dietary Supplement Segmentation
  • Figure 2. OTC Drug and Dietary Supplement- By Geography
  • Figure 3. OTC Drug and Dietary Supplement Overview
  • Figure 4. Analgesics Segment Held Largest Share of OTC Drug and Dietary Supplement
  • Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
  • Figure 6. OTC Drug and Dietary Supplement, by Geography (US$ Million)
  • Figure 7. Global OTC Drug and Dietary Supplement - Leading Country Markets (US$ Million)
  • Figure 8. Global OTC Drug and Dietary Supplement, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South and Central America (SCAM) PEST Analysis
  • Figure 14. OTC Drug and Dietary Supplement Impact Analysis Of Driver And Restraints
  • Figure 15. Global OTC Drug and Dietary Supplement - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global OTC Drug and Dietary Supplement - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global OTC Drug and Dietary Supplement
  • Figure 18. OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
  • Figure 19. Cough and Cold Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Analgesics: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Gastrointestinal Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Sleep Aids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Oral Care Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Ophthalmic Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Antacids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Feminine Care: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
  • Figure 30. Branded: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Generic: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027 (%)
  • Figure 33. Tablets: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. Capsules: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 35. Powders: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 36. Ointments: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 37. Liquid: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 38. Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 39. OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027 (%)
  • Figure 40. Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 41. Retail Stores: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 42. Online Channels: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 43. Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • Figure 44. North America: OTC Drug and Dietary Supplement Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 45. North America: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 46. North America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
  • Figure 47. US: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Canada: OTC Drug And Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Mexico: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. Europe: OTC Drug and Dietary Supplement Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 51. Europe: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
  • Figure 53. Germany: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. France: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. UK: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
  • Figure 56. Italy: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Spain: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 59. Asia-Pacific: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 60. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
  • Figure 61. China: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
  • Figure 62. Japan: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 63. India: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 64. South Korea: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. Australia: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. Middle East & Africa: OTC Drug and Dietary Supplement Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 67. Middle East & Africa OTC Drug and Dietary Supplement Market -Revenue and Forecast to 2027 (USD Million)
  • Figure 68. Middle East & Africa: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
  • Figure 69. Saudi Arabia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 70. UAE: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 71. South Africa: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 72. South and Central America: OTC Drug and Dietary Supplement Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 73. South and Central America OTC Drug and Dietary Supplement Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 74. South and Central America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
  • Figure 75. Brazil: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 76. Argentina: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 77. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement market in North American Countries
  • Figure 78. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in European Countries
  • Figure 79. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in Asia Pacific Countries
  • Figure 80. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in Rest of the World
  • Figure 81. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00012956

Title:
OTC Drug and Dietary Supplement Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Cough and Cold Products, Vitamins and Dietary Supplements, Analgesics, Gastrointestinal Products, Sleep Aids, Oral Care Products, Ophthalmic Products, Antacids, Feminine Care, and Others); Type (Branded and Generic); Form (Tablets, Capsules, Powders, Ointments, Liquid, and Others); Distribution Channel (Hospital and Retail Pharmacies, Retail Stores, Online Channels, and Others), and Geography.

The OTC drug and dietary supplement market was valued at US$ 2, 93,255.40 million in 2019 and is projected to reach US$ 4, 92,102.49 million by 2027; it is expected to grow at a CAGR of 6.8% from 2020 to 2027.

The growth of the OTC drug and dietary supplements marketis mainly attributed to the factors such as growing awareness regarding general health issues and growing preference for non-prescription drugs over prescription drugs. However, the market is likely to get impacted by the drawbacks associated with the stringent FDA regulations related to safety and efficacy of OTC drugs during the forecast period.

Government and consumers' mounting pressure on reducing pricing would help accelerate the prescription to OTC (Rx-to-OTC) transition. There is a widespread support for OTC usage among physicians for fever, cold/cough, and minor ailments of that nature; beyond that, the physicians do have some reservations. Although there are generic prescription medications that are cheaper than OTC drugs, most of the OTC drugs are cheaper than prescription drugs.

OTC drugs need to be ingested in lower dosages compared to prescription drugs. Although there are a few prescription drugs available as OTC drugs, their dosage requirements are much lower when sold OTC, than when they are bought via prescription. In recent years, many prescription allergy medicines such as chlorpheniramine , cetirizine , fexofenadine among othershave been switched to OTC. According to the Consumer Healthcare Products Association, 81% of adults in the US use OTC medicines as their first line of treatment for minor illnesses. On an average, consumers in the country make ~26 trips every year to buy OTC medications. Further, they visit their doctors roughly thrice per year.

Based on Product, the OTC drug and dietary supplement market is segmented into cough and cold products, vitamins and dietary supplements, analgesics, gastrointestinal products, sleep aids, oral care products, ophthalmic products, antacids, feminine care, and others. In 2019, the analgesicssegment accounted for the highest share of the market. Growth of this segment is attributed to the growing awareness regarding general health issues related to body painand growing preference for non-prescription drugs over prescription drugs across the world. However, vitamins and dietary supplementssegment is likely to register the highest CAGR in the global OTC drug and dietary supplements market during the forecast period.

Based on type, the OTC drug and dietary supplementsmarket is segmented into branded and generic. The generic segment held a larger share of the market in 2019 and is estimated to register a higher CAGR of 7.1% in the market during the forecast period.

Based on form, the OTC drug and dietary supplementsmarket is segmented into tablets, capsules, powders, ointments, liquid, and others. The tablets segment held the largest share of the market in 2019 and is estimated to register the highest CAGR of 7.5% in the market during the forecast period.

Based on distribution channel, the OTC drug and dietary supplements market is segmented into hospital and retail pharmacies, retail stores, online channels, and others. The hospital and retail pharmacies segment held the largest share of the market in 2019; whereas, theonline channels segment is estimated to register the highest CAGR of 7.5% in the market during the forecast period.

The Consumer Healthcare Products Association, Council for Responsible Nutrition consumer survey, National Center for Biotechnology Information, The Global Burden of Disease Study, US Food and Drug Administration (FDA),Council for Responsible Nutrition (CRN), and World Health Organization (WHO), are among the major primary and secondary sources referred for preparing this report.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the OTC drug and dietary supplement market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global OTC drug and dietary supplement market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 OTC drug and Dietary Supplement- By Product
    • 1.3.2 OTC Drug and Dietary Supplement- By Type
    • 1.3.3 OTC Drug and Dietary Supplement- By Form
    • 1.3.4 OTC Drug and Dietary Supplement - By Distribution Channel
    • 1.3.5 Global OTC Drug and Dietary Supplement- By Geography

2. OTC Drug and Dietary Supplement - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global OTC Drug And Dietary Supplement- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America (SCAM) - PEST Analysis
  • 4.3 Expert Opinions

5. OTC Drug and Dietary Supplement - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Awareness Regarding General Health Issues
    • 5.1.2 Growing Preference for Non-Prescription Drugs over Prescription Drugs
  • 5.2 Market Restraints
    • 5.2.1 Stringent FDA Regulations Related to Safety and Efficacy of OTC Drugs
  • 5.3 Market Opportunities
    • 5.3.1 R&D Activities by Market Players to Offer Improved OTC Drugs
  • 5.4 Future Trends
    • 5.4.1 Selection of OTC Drugs for Minor Diseases
  • 5.5 Impact Analysis

6. OTC Drug and Dietary Supplement - Global Analysis

  • 6.1 Global OTC Drug and Dietary Supplement Revenue Forecast And Analysis
  • 6.2 Global OTC Drug and Dietary Supplement, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. OTC Drug and Dietary Supplement Analysis - By Product

  • 7.1 Overview
  • 7.2 OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
  • 7.3 Cough and Cold Products
    • 7.3.1 Overview
    • 7.3.2 Cough and Cold Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Vitamins and Dietary Supplements
    • 7.4.1 Overview
    • 7.4.2 Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Analgesics
    • 7.5.1 Overview
    • 7.5.2 Analgesics: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Gastrointestinal Products
    • 7.6.1 Overview
    • 7.6.2 Gastrointestinal Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Sleep Aids
    • 7.7.1 Overview
    • 7.7.2 Sleep Aids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 7.8 Oral Care Products
    • 7.8.1 Overview
    • 7.8.2 Oral Care Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 7.9 Ophthalmic Products
    • 7.9.1 Overview
    • 7.9.2 Ophthalmic Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 7.10 Antacids
    • 7.10.1 Overview
    • 7.10.2 Antacids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 7.11 Feminine Care
    • 7.11.1 Overview
    • 7.11.2 Feminine Care: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 7.12 Others
    • 7.12.1 Overview
    • 7.12.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)

8. OTC Drug and Dietary Supplement Analysis - By Type

  • 8.1 Overview
  • 8.2 OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
  • 8.3 Branded
    • 8.3.1 Overview
    • 8.3.2 Branded: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Generic
    • 8.4.1 Overview
    • 8.4.2 Generic: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)

9. OTC Drug and Dietary Supplement Analysis - By Form

  • 9.1 Overview
  • 9.2 OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027, (%)
  • 9.3 Tablets
    • 9.3.1 Overview
    • 9.3.2 Tablets: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Capsules
    • 9.4.1 Overview
    • 9.4.2 Capsules: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Powders
    • 9.5.1 Overview
    • 9.5.2 Powders: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Ointments
    • 9.6.1 Overview
    • 9.6.2 Ointments: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 9.7 Liquid
    • 9.7.1 Overview
    • 9.7.2 Liquid: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)

10. OTC Drug and Dietary Supplement Analysis - By Distribution Channel

  • 10.1 Overview
  • 10.2 OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027, (%)
  • 10.3 Hospital and Retail Pharmacies
    • 10.3.1 Overview
    • 10.3.2 Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 10.4 Retail Stores
    • 10.4.1 Overview
    • 10.4.2 Retail Stores: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 10.5 Online Channels
    • 10.5.1 Overview
    • 10.5.2 Online Channels: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)

11. OTC Drug and Dietary Supplement Analysis And Forecasts To 2027 - Geographical Analysis

  • 11.1 North America: OTC Drug and Dietary Supplement Market
    • 11.1.1 Overview
    • 11.1.2 North America: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
    • 11.1.3 North America: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 11.1.4 North America: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 11.1.5 North America: OTC Drug and Dietary Supplement Market, By Form - Revenue and Forecast to 2027 (USD Million)
    • 11.1.6 North America: OTC Drug and Dietary Supplement Market, By Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.1.7 North America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
    • 11.1.8 US: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.1 US: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.2 US: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.3 US: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.4 US: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.5 US: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.1.9 Canada: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.1 Canada: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.2 Canada: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.3 Canada: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.4 Canada: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.5 Canada: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.1.10 Mexico: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.1 Mexico: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.2 Mexico: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.3 Mexico: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.4 Mexico: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.5 Mexico: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 11.2 Europe: OTC Drug and Dietary Supplement Market
    • 11.2.1 Overview
    • 11.2.2 Europe: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
    • 11.2.3 Europe: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 11.2.4 Europe: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 11.2.5 Europe: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
    • 11.2.6 Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.2.7 Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
    • 11.2.8 Germany: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.1 Germany: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.2 Germany: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.3 Germany: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.4 Germany: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.5 Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.2.9 France: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.1 France: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.2 France: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.3 France: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.4 France: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.5 France: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.2.10 UK: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.1 UK: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.2 UK: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.3 UK: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.4 UK: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.5 UK: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.2.11 Italy: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.1 Italy: OTC Drug and Dietary Supplement Market,- Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.2 Italy: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.3 Italy: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.4 Italy: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.5 Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.2.12 Spain: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.1 Spain: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.2 Spain: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.3 Spain: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.4 Spain: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.5 Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 11.3 Asia-Pacific: OTC Drug and Dietary Supplement Market
    • 11.3.1 Overview
    • 11.3.2 Asia-Pacific: OTC Drug and Dietary Supplement Market,- Revenue and Forecast to 2027 (USD Million)
    • 11.3.3 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 11.3.4 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 11.3.5 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
    • 11.3.6 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.3.7 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
    • 11.3.8 China: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.1 China: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.2 China: OTC Drug and Dietary Supplement Market,, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.3 China: OTC Drug and Dietary Supplement Market,, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.4 China: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.5 China: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.3.9 Japan: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.1 Japan: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.2 Japan: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.3 Japan: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.4 Japan: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.5 Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.3.10 India: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.1 India: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.2 India: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.3 India: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.4 India: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.5 India: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.3.11 South Korea: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.1 South Korea: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.2 South Korea: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.3 South Korea: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.4 South Korea: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.5 South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.3.12 Australia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.1 Australia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.2 Australia: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.3 Australia: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.4 Australia: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.5 Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 11.4 Middle East & Africa: OTC Drug and Dietary Supplement Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (US$ Million)
    • 11.4.3 Middle East & Africa OTC Drug and Dietary Supplement Market, by Product- Revenue and Forecast to 2027 (USD Million)
    • 11.4.4 Middle East & Africa OTC Drug and Dietary Supplement Market, by Type- Revenue and Forecast to 2027 (USD Million)
    • 11.4.5 Middle East & Africa OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
    • 11.4.6 Middle East & Africa OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.4.7 Middle East & Africa: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
    • 11.4.8 Saudi Arabia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.1 Saudi Arabia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.2 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.3 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.4 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
      • 11.4.8.5 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)
    • 11.4.9 UAE: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.1 UAE: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.2 UAE: OTC Drug and Dietary Supplement Market, by Product- Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.3 UAE: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.4 UAE: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
      • 11.4.9.5 UAE: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.4.10 South Africa: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.10.1 South Africa: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.10.2 South Africa: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.4.10.3 South Africa: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.4.10.4 South Africa: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
      • 11.4.10.5 South Africa: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)
  • 11.5 South and Central America: OTC Drug and Dietary Supplement Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
    • 11.5.3 South and Central America: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 11.5.4 South and Central America: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 11.5.5 South and Central America: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
    • 11.5.6 South and Central America: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)
    • 11.5.7 South and Central America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
    • 11.5.8 Brazil: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.1 Brazil: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.2 Brazil: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.3 Brazil: OTC Drug and Dietary Supplement Market, by Type- Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.4 Brazil: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
      • 11.5.8.5 Brazil: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.5.9 Argentina: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.1 Argentina: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.2 Argentina: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.3 Argentina: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.4 Argentina: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
      • 11.5.9.5 Argentina: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)

12. Impact of COVID-19 Pandemic on Global OTC Drug And Dietary Supplement Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

13. OTC Drug and Dietary Supplement Market- Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. COMPANY PROFILES

  • 14.1 GlaxoSmithKline plc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Sanofi
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Johnson and Johnson Services, Inc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Abbott
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 AbbVie Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Bausch Health Companies Inc.
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Bayer AG
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Procter & Gamble
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Novartis AG
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Reckitt Benckiser Group Plc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 Glossary of Terms
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.